SAP- mice may be useful for studying the role of the SLAM associated protein in cytokine and lymphocyte dysregulation associated with X-linked lymphoproliferative disease.
Pamela L Schwartzberg, National Human Genome Research Institute, National Institutes of Health (NHGRI, NIH)
In SAP- mice, an EGFP and a neomycin (neo) selection cassette were inserted into exon 3 of the X-linked SH2 domain protein 1A (Sh2d1a) gene, abolishing gene expression. The donating investigator reports that the EGFP is non-functional. To assure Sh2d1a was not expressed, a threonine to isoleucine substitution at amino acid 68 (T68I) was introduced in exon 3, upstream of the GFP-PGK-neo cassette. However, the mRNA for this mutant allele is unstable and no protein is made. Sh2d1a encodes a signaling lymphocytic activation molecule (SLAM)-associated protein (SAP) that binds to phosphorylated tyrosine-based motifs in the cytoplasmic tails of the SLAM family surface receptors and links them to downstream signal transduction networks. In the absence of SAP, SLAM family receptors act as strong inhibitory receptors. Mutations in SAP and SAP deficiency have been associated with X-linked lymphoproliferative disease (XLP), a genetic disorder characterized by immune dysregulation and lymphoproliferation caused by fatal responses to Epstein–Barr virus (EBV) infection. XLP leads to symptoms including severe mononucleosis, dysgammaglobulinemia, lymphoproliferation and lymphoma.
SAP- mice exhibit alterations in both CD8+ and CD4+ T cell function, with altered expression of cytokines, severe defects in germinal center formation, defective T follicular helper cell function, and a lack of Natural Killer T cells. Challenge with the infectious agents Toxoplasma Gondii and lymphocyte choriomeningitis virus (LCMV) results in abnormal immune responses, T cell hyperactivation, increased IFN-γ production, decreased B cell function with a lack of long-term antibody responses, and increased morbidity and mortality during chronic infection. Homozygotes are viable and fertile.
Of note, the GFP in these mice is non-functional.
A targeting vector was designed to introduce an enhanced green fluorescent protein (EGFP) and a neomycin (neo) selection cassette into exons 3 of the X-linked SH2 domain protein 1A (Sh2d1a) gene. A threonine to isoleucine substitution at amino acid 68 (T68I) was introduced in exon 3, upstream of the GFP-PGK-neo cassette, to ensure the production of a null allele. The T68I mutation recapitulates mutations found in humans carrying X-linked lymphoproliferative disease (XLP). However, this allele does not generate stable mRNA nor protein. The construct was electroporated into 129S6/SvEvTac-derived TC1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into blastocysts and the resulting chimeric males were bred to C57BL/6J females. These mice SAP- were backcrossed at least 10 generations to C57BL/6J mice. Upon arrival at The Jackson Laboratory, mice were bred to C57BL/6J (Stock No. 000664) for at least one generation to establish the colony.
A 48 SNP (single nucleotide polymorphism) panel analysis, with 43 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. Two of the 43 markers were segregating with 129 on Chromosomes 3 and 16.
|Allele Name||targeted mutation 1, Pamela L Schwartzberg|
|Allele Type||Targeted (Null/Knockout)|
|Allele Synonym(s)||targeted mutation 1, Pamela L Schwartzberg; Sh2d1atm1Pls|
|Gene Symbol and Name||Sh2d1a, SH2 domain containing 1A|
|Gene Synonym(s)||Duncan disease homolog; LYP; XLP; XLPD1; MTCP1; XLPD; EBVS; SAP; RGD1562408; DSHP; IMD5; SAP/SH2D1A|
|Strain of Origin||129S6/SvEvTac|
|Molecular Note||A splice mutation was introduced to the beginning of exon 3 along with an in-frame GFP-PGK-neo cassette. A threonine to isoleucine substitution at amino acid 68 (T68I), a mutation found in human X-linked lymphoproliferative disease (XLP) that inhibits protein binding, was also incorporated to ensure a null allele. Western blot analysis of thymocyte protein from homozygous mutant animals failed to detect a protein product. Antibodies against GFP also failed to detect a protein product.|
When maintaining a live colony, homozygous mice may be bred together.
When using the B6.129S6-Sh2d1atm1Pls/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #025754 in your Materials and Methods section.
|X linked - Heterozygous fenales and wildtype males for Sh2d1a<tm1Pls>|
We will fulfill your order by providing at least two carriers for each strain ordered. The total number, sex, and genotypes provided will vary, although typically 8 or more animals are provided. Please check genotypes which will be recovered. While the genotypes of all animals produced will be communicated to you prior to scheduling shipment, the genotypes of animals provided may not reflect the mating scheme and genotypes described in the strain description. Animals are typically ready to ship in 11-14 weeks. If a second recovery is required to produce the minimum number of animals, then delivery time would increase to approximately 25 weeks. If we fail to produce animals of the correct genotype, you will not be charged. We cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.
Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.